Bivalirudin Has Benefit Beyond Clotting Effect (CME/CE)

(MedPage Today) -- In patients undergoing PCI for ST-segment elevation myocardial infarction, the direct thrombin inhibitor bivalirudin (Angiomax) reduced cardiac mortality independent of its effects on major bleeding.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news